Clinical Trials Directory

Trials / Conditions / Squamous Cell Carcinoma of Esophagus

Squamous Cell Carcinoma of Esophagus

7 registered clinical trials studyying Squamous Cell Carcinoma of Esophagus — 1 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAn Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma
NCT05759325
Guangzhou Institute of Respiratory Disease—
CompletedThe Effect of Andrographis Paniculata (AP) on Palliative Management of Advanced Esophageal Cancer
NCT04196075
Chinese University of Hong KongPhase 3
UnknownA Phase II Trial of Afatinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus
NCT02353936
Yonsei UniversityPhase 2
WithdrawnNeoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus
NCT02041819
Zhejiang UniversityPhase 2
WithdrawnNeoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus
NCT02033538
Zhejiang UniversityPhase 2
TerminatedBenefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.
NCT01248299
Centre Oscar LambretPhase 2
CompletedCombination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
NCT00165490
Dana-Farber Cancer InstitutePhase 2